Germo Hans Gericke

Title: Germo Hans Gericke: Innovator in Pharmaceutical Combinations

Introduction

Germo Hans Gericke is a notable inventor based in Fischingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative combinations for medical treatments. His work focuses on addressing diseases associated with increased stress hormone levels.

Latest Patents

Germo Hans Gericke holds a patent for a unique combination of somatostatin-analogs with 11beta-hydroxylase inhibitors. This invention relates to a combination that includes (a) a somatostatin analog and (b) a 11beta-hydroxylase inhibitor, each in free form or as a pharmaceutical acceptable salt. The patent outlines the use of this combination for preparing a medicament aimed at treating conditions linked to elevated stress hormone levels. It also includes a commercial package or product featuring this combination and describes a method for treating warm-blooded animals, particularly humans.

Career Highlights

Germo Hans Gericke is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to advancements in medical science and improve treatment options for patients.

Collaborations

Germo has collaborated with notable colleagues, including Herbert Schmid and Mario Roberto Maldonado Lutomirsky. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Germo Hans Gericke's innovative work in pharmaceutical combinations exemplifies the impact of research and development in medicine. His contributions continue to pave the way for new treatment options for patients dealing with stress-related health issues.